Cargando…

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Synthetic biology is a powerful tool to create therapeutics which can be rationally designed to enable unique and combinatorial functionalities. Here we utilize non-pathogenic E coli Nissle as a versatile platform for the development of a living biotherapeutic for the treatment of cancer. The engine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leventhal, Daniel S., Sokolovska, Anna, Li, Ning, Plescia, Christopher, Kolodziej, Starsha A., Gallant, Carey W., Christmas, Rudy, Gao, Jian-Rong, James, Michael J., Abin-Fuentes, Andres, Momin, Munira, Bergeron, Christopher, Fisher, Adam, Miller, Paul F., West, Kip A., Lora, Jose M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264239/ https://www.ncbi.nlm.nih.gov/pubmed/32483165 http://dx.doi.org/10.1038/s41467-020-16602-0

Ejemplares similares

STING activation in cancer immunotherapy
por: Su, Ting, et al.
Publicado: (2019)

Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I(+) tumors
por: Wolf, Natalie K., et al.
Publicado: (2022)

A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)

STING cyclic dinucleotide sensing originated in bacteria
por: Morehouse, Benjamin R., et al.
Publicado: (2020)

Stinging insect allergy: current perspectives on venom immunotherapy
por: Ludman, Sian W, et al.
Publicado: (2015)

cGAS-STING, an important pathway in cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2020)

Development of Small-Molecule STING Activators for Cancer Immunotherapy
por: Jung, Hee Ra, et al.
Publicado: (2021)

Scorpion Sting Management at Tertiary and Secondary Care Emergency Departments
por: Al Abri, Suad, et al.
Publicado: (2019)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

The cGAS-STING Pathway: A Promising Immunotherapy Target
por: Ou, Liang, et al.
Publicado: (2021)

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
por: Jiang, Xiaoyi, et al.
Publicado: (2022)

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy
por: Luo, Kewang, et al.
Publicado: (2022)

Cancer immunotherapy strategies that target the cGAS-STING pathway
por: Tian, Zhuoying, et al.
Publicado: (2022)

cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer
por: Dan, Qinfu, et al.
Publicado: (2023)

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
por: Li, Anping, et al.
Publicado: (2019)

Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
Publicado: (2022)

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
por: Wu, You-tong, et al.
Publicado: (2022)

Intracellular bacteria engage a STING-TBK1-MVB12b pathway to enable paracrine cGAS-STING signaling
por: Nandakumar, Ramya, et al.
Publicado: (2019)

Twelve-Hour Ultrarush Immunotherapy in a Patient With Mastocytosis and Hymenoptera Sting Anaphylaxis
por: Jäger, Doris, et al.
Publicado: (2009)

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
por: Zheng, Juyan, et al.
Publicado: (2020)

cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy
por: Long, Zi-Jie, et al.
Publicado: (2022)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy
por: He, Qingbin, et al.
Publicado: (2023)

Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy
por: Dou, Yaling, et al.
Publicado: (2023)

Sting /
por: Leduc, Jean-Marie
Publicado: (1992)

Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy
por: Shae, Daniel, et al.
Publicado: (2019)

Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
por: Li, Kai, et al.
Publicado: (2017)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
por: Zheng, Huan, et al.
Publicado: (2022)

Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy
por: Eitel, Tamara, et al.
Publicado: (2021)

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
por: Su, Ting, et al.
Publicado: (2022)

T‐cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy
por: Hansen, Aida S., et al.
Publicado: (2023)

Design and Development of Mixed Film of Pectin: Ethyl Cellulose for Colon Specific Drug Delivery of Sennosides and Triphala
por: Momin, Munira, et al.
Publicado: (2008)

Optimisation and In Vivo Evaluation of Pectin Based Drug Delivery System Containing Curcumin for Colon
por: Butte, Kishor, et al.
Publicado: (2014)

Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders
por: Chaubey, Pramila, et al.
Publicado: (2020)

Vespa crabro immunotherapy versus Vespula-venom immunotherapy in Vespa crabro allergy: a comparison study in field re-stings
por: Macchia, Donatella, et al.
Publicado: (2018)

First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy
por: Sills, Eric Scott, et al.
Publicado: (2004)

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
por: Shi, Yaoyao, et al.
Publicado: (2020)

Remission of a case of multiple Hymenoptera stings‐associated chronic urticaria during venom immunotherapy
por: Dubini, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u18kls68b2kj7opn2fn9im59v0